Arcadia Biosciences Inc. (RKDA)

AI Score

Unlock

2.85

0.18 (6.63%)

At close: Apr 03, 2025, 3:24 PM

3.06

7.37%

Pre-market: Apr 04, 2025, 08:01 AM EDT

Arcadia Biosciences Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	4.24M	6.52M	20.64M	28.68M	14.04M	8.42M	12M	9.13M	2.01M	23.97M	16.57M	2.83M	5.35M
Short-Term Investments	n/a	5.12M	n/a	n/a	11.63M	16.91M	9.82M	3.9M	48.55M	26.27M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	2M	n/a	n/a	n/a	2.5M	19.75M	500K	1.43M	2.77M
Other Long-Term Assets	4.06M	3.52M	932K	2.67M	5.51M	372K	753K	1.22M	1.35M	1.89M	4.97M	2.6M	1.58M
Receivables	3.07M	514K	1.22M	1.37M	1.41M	602K	168K	1.24M	533K	788K	1.42M	1.02M	1.24M
Inventory	904K	1.96M	2.57M	4.43M	3.81M	1.79M	181K	229K	252K	294K	424K	450K	898K
Other Current Assets	1.03M	858K	1.21M	900K	811K	712K	n/a	n/a	n/a	n/a	n/a	n/a	398K
Total Current Assets	9.24M	14.97M	25.4M	35.39M	31.7M	28.44M	22.88M	15.05M	52.22M	52.02M	18.7M	4.57M	7.88M
Property-Plant & Equipment	178K	1.18M	2.55M	5.37M	9.37M	3.76M	395K	299K	508K	585K	728K	941K	1.13M
Goodwill & Intangibles	39K	39K	40K	484K	778K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.28M	4.73M	3.52M	8.53M	15.65M	4.13M	1.15M	1.52M	4.35M	22.23M	6.19M	4.97M	5.48M
Total Assets	13.52M	19.7M	28.92M	43.92M	47.35M	32.57M	24.02M	16.57M	56.57M	74.24M	24.89M	9.54M	13.36M
Account Payables	703K	801K	905K	1.41M	726K	492K	285K	366K	222K	424K	244K	220K	137K
Deferred Revenue	n/a	n/a	n/a	64K	8K	42K	96K	1M	740K	1.01M	830K	1.07M	1.16M
Short-Term Debt	155K	n/a	1.01M	1.07M	1.86M	635K	n/a	n/a	n/a	n/a	5.61M	4.57M	n/a
Other Current Liabilities	1.68M	634K	-89K	-125K	583K	2.64M	1.58M	88K	197K	193K	2.44M	2.29M	140K
Total Current Liabilities	2.56M	3.59M	4.21M	5.04M	6.31M	5.71M	3.05M	3.52M	3.13M	3.45M	11.27M	9.54M	3.36M
Long-Term Debt	n/a	n/a	n/a	n/a	2.1M	107K	n/a	n/a	25.13M	24.93M	8.87M	9.92M	8M
Other Long-Term Liabilities	4.73M	3.26M	2.81M	5.46M	4.99M	16.94M	8.15M	3M	3M	3M	3M	3M	3M
Total Long-Term Liabilities	4.73M	3.41M	3.81M	7.68M	12.48M	18.54M	8.15M	5.04M	31.25M	30.57M	15.51M	17.3M	15.69M
Total Liabilities	7.29M	7M	8.02M	12.72M	18.8M	24.25M	11.21M	8.56M	34.38M	34.02M	26.77M	26.84M	19.04M
Total Debt	155K	1.01M	2.02M	3.29M	9.35M	2.24M	n/a	n/a	25.13M	24.93M	14.47M	14.56M	8M
Common Stock	65K	65K	65K	63K	54K	49K	45K	42K	44K	44K	n/a	n/a	n/a
Retained Earnings	-278.88M	-271.84M	-257.86M	-226.49M	-211.82M	-207.17M	-178.37M	-167.26M	-151.55M	-131.93M	-113.97M	-95.63M	-82.44M
Comprehensive Income	n/a	101K	n/a	0.00	-0.00	1K	-4.8M	-1K	-19K	-115K	n/a	n/a	n/a
Shareholders Equity	6.22M	12.84M	21.03M	31.09M	27.73M	7.71M	12.81M	8.01M	22.2M	40.23M	-1.89M	-17.3M	-5.68M
Total Investments	n/a	5.12M	n/a	n/a	11.63M	16.91M	9.82M	3.9M	51.05M	46.02M	500K	1.43M	2.77M